Journal article
N-acetylcysteine interference of Trinder-based assays
Clinical biochemistry, Vol.49(1-2), pp.100-104
01/2016
DOI: 10.1016/j.clinbiochem.2015.10.005
PMID: 26500003
Abstract
The primary objective of this study was to evaluate potential interference of Trinder-based chemistry assays by N-acetylcysteine (NAC). A secondary objective was to look for evidence of interference in patients treated with NAC for acetaminophen (APAP) overdose.
Dilutions of NAC in plasma were tested for interference using the following Roche Diagnostics Trinder-based assays on a cobas 8000 system: enzymatic creatinine (Cr), cholesterol (CHOL), high-density lipoprotein cholesterol (HDL-C), triglycerides (TRIG), and uric acid (UA). Two non-Trinder Roche assays — urea nitrogen (BUN) and glucose (GLUC) — were tested as controls. Sekisui N-geneous® low-density lipoprotein cholesterol (LDL-C) reagent was also evaluated. Retrospective chart review of APAP overdose cases over 49months was conducted to look for differences in plasma Cr before and after intravenous (IV) NAC administration.
NAC concentrations (shown in parentheses) that caused ≥10% inhibition for individual assays were (in order of sensitivity to interference): TRIG (570mg/L)>CHOL (740mg/L)≈Cr (790mg/L)>UA (1100mg/L)>HDL-C (1760mg/L)>LDL-C (2900mg/L). Neither BUN nor GLUC achieved significant inhibition up to 10,000mg/L NAC. Evidence for relatively minor inhibition of Cr was observed in patients after NAC administration.
NAC inhibition of the assays investigated typically occurs at concentrations higher than expected during IV and oral NAC therapy.
•N-acetylcysteine (NAC) interference of Trinder-based assays has been reported.•Serial dilutions of NAC were created to characterize this interference.•Thresholds indicating 10% inhibition of Trinder-based assays by NAC were derived.•Intravenous (IV) NAC is used for the treatment of acetaminophen (APAP) overdose.•Minor inhibition of enzymatic creatinine (Cr) during such treatment was observed.
Details
- Title: Subtitle
- N-acetylcysteine interference of Trinder-based assays
- Creators
- Jonathan R Genzen - ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, 500 Chipeta Way, Salt Lake City, UT 84108, USAJoshua J Hunsaker - ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, 500 Chipeta Way, Salt Lake City, UT 84108, USALouis S Nelson - Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, 200 Hawkins Drive, Iowa City, IA 52242, USABrett A Faine - Department of Emergency Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, 200 Hawkins Drive, Iowa City, IA 52242, USAMatthew D Krasowski - Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, 200 Hawkins Drive, Iowa City, IA 52242, USA
- Resource Type
- Journal article
- Publication Details
- Clinical biochemistry, Vol.49(1-2), pp.100-104
- DOI
- 10.1016/j.clinbiochem.2015.10.005
- PMID
- 26500003
- NLM abbreviation
- Clin Biochem
- ISSN
- 0009-9120
- eISSN
- 1873-2933
- Publisher
- Elsevier Inc
- Language
- English
- Date published
- 01/2016
- Academic Unit
- Pathology; Emergency Medicine; Pharmacy Practice and Science
- Record Identifier
- 9984046832702771
Metrics
19 Record Views